Quinolone-based first, second and third-line therapies for Helicobacter pylori

doi:10.5497/wjp.v4.i4.274

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7474)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

478

WORD

286

HTML

3181

Tables (1-1)

349

Sum=4294

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1156

Download

2024

Sum=3180

Dec 9, 2015 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Pharmacol. Dec 9, 2015; 4(4): 274-280
Published online Dec 9, 2015. doi: 10.5497/wjp.v4.i4.274

Full Size Figure Download Figure

$[Label] $[Caption_0] $[Caption_1]

Citation: Ierardi E, Losurdo G, Giorgio F, Iannone A, Principi M, Leo AD. Quinolone-based first, second and third-line therapies for Helicobacter pylori. World J Pharmacol 2015; 4(4): 274-280
URL: https://www.wjgnet.com/2220-3192/full/v4/i4/274.htm
DOI: https://dx.doi.org/10.5497/wjp.v4.i4.274